About Hytanbio Tech
Hong Kong-based Hytanbio Tech coordinates oral film formulation, manufacturing, packaging and OEM/ODM/CRO/CDMO development across a Mainland China network.
Formula review
Define ingredients, format and destination-market requirements.
Prototype discussion
Agree sample objectives and record feedback against the brief.
Documented decisions
Review applicable evidence and confirm the specification.
Packaging protection
Match the protective sachet and retail structure to the film.
Commercial handover
Confirm quality documents, approvals and trade responsibilities.
About Hytanbio Tech
- Who coordinates the project?
- How do manufacturing and R&D capabilities relate?
- Which capabilities apply to oral films?
Founded in 2026 and headquartered in Hong Kong, Hytanbio Tech was established to coordinate global overseas business development and specialized biological research projects. Our core in-house commercial manufacturing base in Shaoxing, Mainland China, was commissioned in 2014.
For this website, our focus is oral dissolving film development: energy and nutritional concepts, formulation feasibility, prototype sampling, custom packaging and full-chain OEM / ODM / CRO / CDMO project support.
We connect brand and laboratory briefs with the technical, manufacturing and documentation work needed to define a controlled project.
Company-supplied facility image. Site identity and applicable documentation are reviewed during project qualification.
A broader research and manufacturing platform
Our wider group platform includes peptide raw materials, lyophilized peptide powders, cosmetic delivery systems, dissolvable oral films and microneedle development. The company profile describes a 4,000+ square-metre R&D centre with more than 40 master’s- and doctoral-level researchers, supported by facilities across Shanghai, Guangzhou and Changzhou.
The microneedle hub is in Changzhou, Jiangsu. The supplied profile describes ISO 13485 and ISO 9001 certification and capacity of up to one million dissolvable microneedle units per day for that operation. Those figures and certificates are specific to the microneedle system and are not presented as oral film output or oral film certification.
The peptide platform described in the company profile includes synthesis lines, large-format synthesizers, analytical and preparative HPLC systems and GMP-compliant clean laboratories, with an ISO 9001:2015 quality system. Applicable capability, site scope and current documents are confirmed for each oral film or research project.
What your project team can expect
Feasibility first
Ingredient, payload, process, taste and market questions before firm specifications.
Written handovers
Defined sample objectives, approval points, acceptance criteria and responsibilities.
Traceable records
Agreed material and batch documentation tied to the actual manufacturing site.
Export coordination
Quality documents, packaging and trade arrangements aligned with the destination brief.
We support nutritional and wellness brands, cosmetic businesses where relevant to the project, research laboratories, cross-border distributors and private label teams. Product classification, lawful use, labeling and destination-market requirements remain project-specific. Company profile information is supplied by the business; current supporting documents are reviewed during qualification.
Answers for your next project
Clear starting points for formulation, commercial terms and market review.
Does the microneedle production capacity describe oral film output?
No. The supplied company profile assigns that capacity to microneedles. Oral film output, equipment suitability and commercial capacity are assessed for the actual project and site.